Master thesis : Genetic engineering of senescence and cell death (m/f/d)

CeMM Forschungszentrum für Molekulare Medizin GmbH

Wien

Sur place

EUR 14 000 - 17 000

Temps partiel

Il y a 5 jours
Soyez parmi les premiers à postuler

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Avantages offerts par ce poste

Relocation reimbursement
Visa support
Part-time schedule

Résumé du poste

CeMM Research Center for Molecular Medicine invites a motivated master’s thesis student to join a project on genetic engineering of senescence and cell death. The position is 12 months and includes hands‑on training in wet-lab biology within a collaborative lab led by Christoph Bock.

The project combines CRISPR, cell death, and aging, with opportunities to contribute to scientific publications and publications.

Qualifications

  • Enrollment in a master's program in molecular biology, biotechnology, biomedicine, or a related field.
  • Solid fundamentals in molecular biology techniques including mammalian cell culture.
  • At least one year of hands‑on wet‑lab work in a biology or biomedical lab.
  • Good command of English and careful laboratory work.

Responsabilités

  • Design and molecular cloning of genetic constructs for senescence and cell death.
  • Produce viral vectors and deliver into human cells and organoid models.
  • Engineer and maintain reporter and effector cell lines with clonal selection.
  • Quantitatively validate by flow cytometry, microscopy, and sequencing readouts.
  • Collaborate with partner groups to characterize constructs in model systems.

Connaissances

Master's enrollment
Molecular biology basics
Wet-lab experience
English proficiency

Formation

Master's program in molecular biology/biomedicine/biotechnology

Outils

Mammalian cell culture

Description du poste

Master thesis : Genetic engineering of senescence and cell death (m/f/d)

We are recruiting an ambitious master’s thesis student who wants to pursue groundbreaking biomedical research. This position requires a 12-month commitment. The successful candidate will join the research group led by Christoph Bock at the CeMM Research Center for Molecular Medicine (Austrian Academy of Sciences). The project combines CRISPR, cell death, and aging. It is primarily wet-lab and benefits from a technology development / cell engineering mindset.

The Candidate

We are seeking a motivated master’s thesis student with prior fulltime experience in wet-lab biology (e.g., as part of an experimental Bachelor thesis project and internships). The project is scientifically and technically challenging, and you will receive hands‑on training in a highly supportive and collaborative environment, with the opportunity to contribute to scientific publications. Our research group has a track record of successful mentorship ().

Required experience and skills

  • Enrollment in a master’s program in molecular biology, biotechnology, biomedicine, or a related field (proof of enrollment required).
  • Solid fundamentals in molecular biology techniques including mammalian cell culture.
  • At least one year of previous hands‑on wet‑lab work in a biology or biomedical research lab
  • Good command of English and a careful, structured way of working in the laboratory.

Desirable experience and skills

  • Familiarity with CRISPR–Cas systems, lentiviral or AAV production, recombinase or Cre/lox-based systems, flow cytometry, fluorescence microscopy, or related methods.
Training and Supervision

You will be trained in the methods listed below, including biosafety training for work with viral vectors, as part of the research group led by Christoph Bock. Day‑to‑day supervision will be provided by postdoctoral fellow Mihaela Peycheva.

Typical Tasks

  • Design and molecular cloning of genetic constructs for induction of senescence and cell death.
  • Production of viral vectors and delivery into human cell lines, primary cells, and organoid models.
  • Engineering and maintenance of reporter and effector cell lines, including clonal selection and genotyping.
  • Quantitative validation by flow cytometry, microscopy, senescence and apoptosis assays, and sequencing readouts.
  • Characterization of validated constructs in mouse and human model systems, in collaboration with partner groups.
The Research Group ()

We seek to advance biomedicine with technology‑driven research, combining experimental and computational approaches to understand and program epigenetic cell states and to develop cell‑based therapies for cancer and immune diseases.

Main areas of research include:

  • Bioinformatics. Computational methods are essential for data‑driven biomedical research. We develop algorithms and software for large‑scale data analysis, and we pursue clinical collaborations to establish medical impact.
  • Single‑cell biology. Epigenetic cell states contribute broadly to the regulation of human organs. As part of the , we use single‑cell and spatial sequencing to dissect their role in tissue homeostasis and pathogenesis.
  • Machine learning. Huge datasets pose new analytical challenges. As part of the , we develop methods for interpretable deep learning and artificial intelligence in biomedicine.
  • Biotechnology. Groundbreaking discoveries are often enabled by new technology. We develop and apply innovative methods in the areas of single‑cell sequencing, CRISPR screening, epigenome editing, and synthetic biology.
  • Cell therapy. CAR T cells have shown dramatic efficacy for blood cancers and spearhead a broader shift toward personalized cell‑based therapies. We use high‑throughput technology to design synthetic immune cells as therapeutics.

The Principal Investigator ()

Christoph Bock is a Principal Investigator at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and Professor of [Bio]Medical Informatics at the Medical University of Vienna. He is also the scientific coordinator of the Biomedical Sequencing Facility at CeMM, member of the Human Cell Atlas Organizing Committee, fellow of the European Lab for Learning and Intelligent Systems (ELLIS), and co‑founder of two Vienna‑based start‑up companies (Myllia, Neurolentech). He has received major research awards, including consecutive ERC Starting, Consolidator, and Advanced Grants (2016 to 2032), the Otto Hahn Medal of the Max Planck Society (2009), Overton Prize of the International Society for Computational Biology (2017), and the Erwin Schrödinger Prize of the Austrian Academy of Sciences (2022), and he has been included in the global list of "Highly Cited Researchers" by Clarivate Analytics (ISI Web of Science) each year since 2019.

About the Institute

CeMM is an international research institute of the Austrian Academy of Sciences and a founding member of EU‑LIFE. The mission of CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences is to achieve maximum scientific innovation in molecular medicine to improve healthcare. At CeMM, an international and creative team of scientists and medical doctors pursues free‑minded basic life science research in a large and vibrant hospital environment of outstanding medical tradition and practice. At CeMM, an international and creative team of scientists and medical doctors pursues free‑minded basic life science research in a large and vibrant hospital environment of outstanding medical tradition and practice. CeMM’s research is based on post‑genomic technologies and focuses on societally important diseases, such as immune disorders and infections, cancer, aging and metabolic disorders. CeMM operates in a unique mode of super‑cooperation, connecting biology with medicine, experiments with computation, discovery with translation, and science with society and the arts. CeMM discovers and develops technologies to explore human biology with the purpose of defeating disease at its roots. Because Science is our Medicine! CeMM trains a modern blend of biomedical scientists and is located at the campus of the General Hospital and the Medical University of Vienna. CeMM is a proud recipient of the HR Excellence in Research Award (HRS4R). This award indicates that CeMM takes care of the well‑being of its employees, that the recruitment process is open, fair, and transparent, and that CeMM offers professional appraisals and career development procedures. More than 150 people from 49 nationalities are working at CeMM. The institute promotes equal opportunity and harbors a mix of different talents, backgrounds, competences, and interests.

We offer
  • Work within an experienced, interdisciplinary, and international team at one of Austria’s leading research institutes
  • Ample opportunities to contribute and gain experience in a key area of biomedical research and precision medicine
  • An inspiring workplace with an international setting, strong team spirit, and an excellent work climate
  • A wide range of social, cultural, and sports activities organized by the institute
  • Excellent employee benefits including full insurance coverage (health, accident, retirement), health care services, subsidized cafeteria
  • Monthly gross salary of EUR1.379,60 for 20 hours/ week (following the)
  • Support for relocating to Vienna is provided (relocation reimbursement, visa support, etc.)

Applications will be reviewed on a rolling basis. Any application received by 6 January 2027 will be considered. Anticipated start date: flexible.

Additional information

City Vienna

Position type Part‑time employee

Start of work 01.03.2027

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Master thesis : Genetic engineering of senescence and cell death (m/f/d)
Master thesis : Genetic engineering of senescence and cell death (m/f/d)

CeMM • Wien

Sur place
EUR 14 000 - 17 000
Relocation support
Full insurance coverage
Biomedical Data Scientist / Bioinformatician: Immunotherapy & AI (m/f/d)
Biomedical Data Scientist / Bioinformatician: Immunotherapy & AI (m/f/d)

Research Center for Molecular Medicine (CeMM), ÖAW • Wien

Sur place
EUR 60 000 - 81 000
International team
Relocation support
Excellent work climate
Biomedical Data Scientist / Bioinformatician: Immunotherapy & AI (m/f/d)
Biomedical Data Scientist / Bioinformatician: Immunotherapy & AI (m/f/d)

CeMM Forschungszentrum für Molekulare Medizin GmbH • Wien

Sur place
EUR 63 000 - 77 000
Full insurance coverage
Relocation support
Visa support
+2
Adjunct Principal Investigator positions for experts in Pain/Nociception Research (all genders)
Adjunct Principal Investigator positions for experts in Pain/Nociception Research (all genders)

CeMM Forschungszentrum f?r Molekulare Medizin GmbH • Wien

Sur place
EUR 68 000 - 83 000
Adjunct PI package
ERC grant support
International environment
Adjunct Principal Investigator positions for experts in Pain/Nociception Research
Adjunct Principal Investigator positions for experts in Pain/Nociception Research

CeMM • Wien

Sur place
EUR 64 000 - 86 000
€75,000/year package
Laboratory facilities
ERC grant support
+1
Adjunct Principal Investigator Positions for Experts in Pain/Nociception Research (all genders)
Adjunct Principal Investigator Positions for Experts in Pain/Nociception Research (all genders)

CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences • Wien

Sur place
EUR 68 000 - 83 000
5-year collaboration
€75,000 per year
Fully equipped laboratory
+2
Postdoctoral Researcher (m/f/x)
Postdoctoral Researcher (m/f/x)

Meduniwien • Wien

Hybride
EUR 63 000 - 77 000
Employer-Sponsored Retirement Plan
Employee Discounts
Stable Employer
+1
Senior Scientist, Max Perutz Labs
Senior Scientist, Max Perutz Labs

University of Vienna • Wien

Sur place
EUR 52 000 - 62 000
Flexible hours
Hybrid/remote work options
Internal training opportunities
Graduate Project Assistant (Diploma/Master)
Graduate Project Assistant (Diploma/Master)

Johannes Kepler University • Autriche

Sur place
PEN 147 000 - 176 000
Salary €3,776.10 gross/mo
Campus environment
Educational opportunities
+2
Research Group Leader in Cardiopulmonary Molecular Biology (m/f/x)
Research Group Leader in Cardiopulmonary Molecular Biology (m/f/x)

Medizinische Universität Wien • Wien

Sur place
EUR 61 025 - 73 095
Job ticket as a contribution to climate protection
Secure employer with a pleasant working atmosphere
Company pension scheme
+6